CClinicalTrials.gg
CompletedNCT00839098Updated Feb 4, 2016Results posted

Powered Seating Function Usage Among Veterans - Compliance and Coaching

An interventional study of Instruction Group: Power seat function usage instruction- verbal and written instruction and Instruction and Virtual Coach Group: Power seat function usage instruction- verbal, written, and virtual coach in Use of Power Wheelchairs and Power Seat Functions, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-02-04.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this randomized control study is to evaluate the use of electric powered wheelchairs and powered seating function patterns of Veterans to determine how usage patterns relate to activity, participation, and seating discomfort. In addition, it will be determined if a training program or a training program with a virtual coach will improve compliance of clinical practice guidelines for pressure relief, upper limb preservation, and discomfort management. The virtual coach is a portable, programmable intelligent reminder designed to enhance a person's use of their power wheelchair and power seat functions.

Read the detailed description

This is a randomized control trial evaluating power seat function usage among 3 groups: 1) standard of care- verbal instruction 2) verbal and written instruction and 3) same as #2 with addition of virtual coach. This study will be conducted in two phases. Phase I data will be collected for 8 weeks, during the time period that the subject is awaiting for delivery of their personal electric powered wheelchair (EPW) with powered seat functions. Phase II data will be collected for a total of 4 weeks, after the subject receives their personal wheelchair. During Phase I, Visit I, subjects will be fitted for a study EPW with powered seat functions. All subjects will be provided with the "standard of care" training on driving of the wheelchair and usage of the power seating functions. Subjects will be instructed to go about their daily activities as they normally would, while the instrumented wheelchair will track their usage of the wheelchair and seating habits. Phase I, Visit II-IV, subjects will be randomized into one of three study groups: Control Group; Instruction Group; and Instruction \& Virtual Coach Group. Subjects assigned to the Control Group will receive 'standard of care.' Subjects assigned to the Intervention Group will receive the "standard of care" and additional written instructional materials and feedback regarding activity and wheelchair usage. Subjects assigned to the Instruction \& Virtual Coach Group will receive the same training and instructional materials as the Intervention Group. This group will also be instructed in use of the virtual coach system, which will be active during the in-home usage periods to provide personalized feedback. Phase II will involve mounting a wheelchair and seat function usage datalogger to the subject's personal wheelchair over a period of 4 weeks.

02

Conditions studied

  • Use of Power Wheelchairs and Power Seat Functions

Keywords

  • power wheelchairs
  • assistive technology
  • rehabilitation
03

In context

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,733 studies on the registry; 396 are open to participants now.

Of its 206 completed or terminated interventional studies of FDA-regulated products, 180 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Subjects must be 18 years of age or older.
  • A power wheelchair with power seat functions must be recommended as medically necessary by a qualified clinician with ATP credential or board certified in physical medicine and rehabilitation from the VAPHS Wheelchair and Seating Clinic or the Center for Assistive Technology.
  • Subjects must be able to be properly fitted with one of the study EPWs; 18" or 20" seat widths will be available. Cushions and backrests will be made available to meet subject's clinical needs.
  • Subject's home must be accessible to accommodate use of a power w/c.
  • Subject must be determined to be fully capable of examining his/her sitting surface daily for redness or pressure ulcers or if not that another individual can be designated as able and willing to-do this.

Exclusion criteria

Exclusion Criteria:

  • Subjects who have active pelvic, gluteal or thigh wounds or who have had a pressure ulcer in these regions within the past 30 days. (They may be worsened by prolonged sitting).
  • Subjects who report more than 5 days of hospitalization in the previous month. (They may not spend enough time using an EPW with powered seating functions).
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
28 participants (actual)

Study arms

  • No intervention
    Control Group

    Control Group

  • Experimental
    Instruction Group

    Instruction Group

    Other: Instruction Group: Power seat function usage instruction- verbal and written instruction

  • Experimental
    Instruction and Virtual Coach Group

    Instruction and Virtual Coach Group

    Other: Instruction and Virtual Coach Group: Power seat function usage instruction- verbal, written, and virtual coach

Interventions

  • OtherInstruction Group: Power seat function usage instruction- verbal and written instruction

    Subjects assigned to the Intervention Group will be assigned to an Intervention Group Clinician. The Intervention Group Clinicians will provide the same training as the Control Group Clinicians, with the addition of discussing the Veteran's activity and seating function usage data, reviewing and providing a study pamphlet and compact disk as a reference guide on use of power seat functions.

  • OtherInstruction and Virtual Coach Group: Power seat function usage instruction- verbal, written, and virtual coach

    Subjects assigned to the Instruction \& Virtual Coach Group will be assigned to an Intervention Group Clinician and will receive the same training and instructional materials as the Instruction Group. Subjects will also be instructed in use of the virtual coach system, which will be active during the in-home usage periods to provide personalized feedback. As the Virtual Coach is a dynamic intelligent system, it will adjust its coaching to the needs of the individual. For example, if the person is compliant, the Virtual Coach will give positive feedback and then gradually transition to operating quietly in the background. If a person is not fully compliant, it will alter feedback modes (e.g., verbal cues, auditory tones, visual cues) and timing to attempt to increase compliance.

06

What researchers measure

Primary outcomes

  1. Compliance Rate

    Compliance rate is a measure of compliance with the recommendation of using powered seating functions (moderate or maximum range of tilt, at least once every hour, for 2 minutes). The participant had to follow the recommended position, duration, and frequency to be considered as compliant and performed successful repositioning exercise. The compliance rate of a participant was the number of successful repositioning exercise divided by the sum of the number of successful repositioning exercise and missed repositioning exercise. The result of the difference between the baseline and week 7-8 (last 2 weeks) was shown here.

    Time frame: Every 2 weeks for 8 weeks following acquisition of wheelchair

  2. Frequency of Power Seat Function Usage

    Frequency of power seat function usage was measured by the number of times of changing tilt and recline angles averaged by the duration that the participant occupied the wheelchair per day. The results of the difference between the baseline and week 7-8 (last 2 weeks) were shown here.

    Time frame: Every 2 weeks for 8 weeks following acquisition of wheelchair

  3. Power Wheelchair Usage

    Power wheelchair usage was measured by the sum of distances that the power wheelchair traveled (km) divided by the duration of the wheelchair being occupied a day (hr). The result of the difference between the baseline and week 7-8 (last 2 weeks) was shown here.

    Time frame: Every 2 weeks for 8 weeks following acquisition of wheelchair

  4. Wheelchair Occupancy

    Wheelchair occupancy was measured by the sum of duration that the seat of the wheelchair was occupied. The results of the difference between the baseline and week 7-8 (last 2 weeks) were shown here.

    Time frame: Every 2 weeks for 8 weeks following acquisition of wheelchair

Secondary outcomes

  1. Questionnaire Responses: Tool for Assessing Wheelchair Discomfort (TAWC)

    General Discomfort Assessment (GD) and Discomfort Intensity Rating (DI) are two sub-scales of TAWC. Higher scores indicate greater discomfort. GD consists of 8 discomfort statements and 5 comfort statements. The statements are rated on a seven point Likert scale, from strongly disagree to strongly agree of points from 1-7 (total score: 13-91). DI includes seven body areas (back, neck, buttocks, legs, arms, feet, and hands) and overall discomfort level, rated for a degree of discomfort intensity on a scale of 0 (no discomfort) to 10 (severe discomfort). Space is also included for the user to list additional body areas. DI scores may range from 0 to more than 80, depending on whether the participant reported additional areas of discomfort. Although GD and DI were measured daily, the data were average for each two-week period. The average GD and DI of the difference between the baseline and week 7-8 (last 2 weeks) were shown here.

    Time frame: Every 2 weeks for 8 weeks following acquisition of wheelchair

  2. Questionnaire Responses: Psychological Impacts of Assistive Devices Scale

    This tool is to measure perceived psychological impact of using an assistive device. It consists of three subscales, Competence (12 items), Adaptability (6 items), and Self-esteem (8 items). Each item is scored on a likert scale from -3 (decreases) to + 3 (increases). The total score is the sum of all 26 items, ranging from -78 to 78. A higher positive score indicates more positive impact. A negative score indicates negative impact. The differences between the measurements taken at the end of 2nd week (end of baseline) and the end of 8th week (end of intervention period) are reported here to show the intervention effect.

    Time frame: At the end of every two weeks

  3. Questionnaire Responses: Independence in Community

    This outcome was measured in three aspects: Physical Independence, Cognitive Independence, and Mobility, using the three of the subscales of Craig Handicap Assessment and Reporting Technique Scale. The scores of each subscale has to be calculated with specific formula and weight based on the manual. The range of each subscale score are: Physical Independence: 28-100; Cognitive Independence: 15-100; and Mobility: 16-100. A higher score indicates greater independence. The analyzed results of the difference between the measurements at the end of 2nd week and 8th week were shown here.

    Time frame: At the end of 2nd (end of baseline) week and 8th week (end of intervention period) following acquisition of wheelchair

07

Results

Posted Feb 4, 2016
Limitations and caveats
It was difficult to recruit power wheelchair users to participate in the study. Participants withdrew from the study because the study wheelchair could not meet their needs, or they could not use the Virtual Seating Coach independently.

Participant flow

Participant flow — Overall Study
MilestoneControl GroupInstruction GroupInstruction and Virtual Coach Group
Started31213
Completed1116
Not completed217
Withdrew: Withdrawal by subject217

Outcome measures

PrimaryCompliance Rate

Compliance rate is a measure of compliance with the recommendation of using powered seating functions (moderate or maximum range of tilt, at least once every hour, for 2 minutes). The participant had to follow the recommended position, duration, and frequency to be considered as compliant and performed successful repositioning exercise. The compliance rate of a participant was the number of successful repositioning exercise divided by the sum of the number of successful repositioning exercise and missed repositioning exercise. The result of the difference between the baseline and week 7-8 (last 2 weeks) was shown here.

Time frame:
Every 2 weeks for 8 weeks following acquisition of wheelchair
Reported as:
Mean · Percentage of participants' compliance
Compliance Rate
Percentage of participants' complianceArm 1: Control GroupArm 2: Instruction GroupArm 3: Instruction + VSC Group
Compliance Rate—8.9 ± 15.939.7 ± 23.5
Statistical analysis
  • Arm 2: Instruction Group vs Arm 3: Instruction + VSC Group · Wilcoxon (Mann-Whitney) · p = 0.27
SecondaryQuestionnaire Responses: Tool for Assessing Wheelchair Discomfort (TAWC)

General Discomfort Assessment (GD) and Discomfort Intensity Rating (DI) are two sub-scales of TAWC. Higher scores indicate greater discomfort. GD consists of 8 discomfort statements and 5 comfort statements. The statements are rated on a seven point Likert scale, from strongly disagree to strongly agree of points from 1-7 (total score: 13-91). DI includes seven body areas (back, neck, buttocks, legs, arms, feet, and hands) and overall discomfort level, rated for a degree of discomfort intensity on a scale of 0 (no discomfort) to 10 (severe discomfort). Space is also included for the user to list additional body areas. DI scores may range from 0 to more than 80, depending on whether the participant reported additional areas of discomfort. Although GD and DI were measured daily, the data were average for each two-week period. The average GD and DI of the difference between the baseline and week 7-8 (last 2 weeks) were shown here.

Time frame:
Every 2 weeks for 8 weeks following acquisition of wheelchair
Reported as:
Mean · units on a scale
Questionnaire Responses: Tool for Assessing Wheelchair Discomfort (TAWC)
units on a scaleArm 1: Control GroupArm 2: Instruction GroupArm 3: Instruction + VSC Group
General Discomfort: Difference—4.6 ± 7.5-7.4 ± 16.9
Discomfort Index: Difference—1.8 ± 10.0-12.1 ± 13.6
Statistical analysis
  • Arm 2: Instruction Group vs Arm 3: Instruction + VSC Group · Wilcoxon (Mann-Whitney) · p = >0.05
SecondaryQuestionnaire Responses: Psychological Impacts of Assistive Devices Scale

This tool is to measure perceived psychological impact of using an assistive device. It consists of three subscales, Competence (12 items), Adaptability (6 items), and Self-esteem (8 items). Each item is scored on a likert scale from -3 (decreases) to + 3 (increases). The total score is the sum of all 26 items, ranging from -78 to 78. A higher positive score indicates more positive impact. A negative score indicates negative impact. The differences between the measurements taken at the end of 2nd week (end of baseline) and the end of 8th week (end of intervention period) are reported here to show the intervention effect.

Time frame:
At the end of every two weeks
Reported as:
Mean · units on a scale
Questionnaire Responses: Psychological Impacts of Assistive Devices Scale
units on a scaleArm 1: Control GroupArm 2: Instruction GroupArm 3: Instruction + VSC Group
Questionnaire Responses: Psychological Impacts of Assistive Devices Scale—11.1 ± 17.7-8.4 ± 15.6
Statistical analysis
  • Arm 2: Instruction Group vs Arm 3: Instruction + VSC Group · Wilcoxon (Mann-Whitney) · p = 0.04
SecondaryQuestionnaire Responses: Independence in Community

This outcome was measured in three aspects: Physical Independence, Cognitive Independence, and Mobility, using the three of the subscales of Craig Handicap Assessment and Reporting Technique Scale. The scores of each subscale has to be calculated with specific formula and weight based on the manual. The range of each subscale score are: Physical Independence: 28-100; Cognitive Independence: 15-100; and Mobility: 16-100. A higher score indicates greater independence. The analyzed results of the difference between the measurements at the end of 2nd week and 8th week were shown here.

Time frame:
At the end of 2nd (end of baseline) week and 8th week (end of intervention period) following acquisition of wheelchair
Reported as:
Mean · units on a scale
Questionnaire Responses: Independence in Community
units on a scaleArm 1: Control GroupArm 2: Instruction GroupArm 3: Instruction + VSC Group
Phy. Independence: Difference—9.5 ± 55.68.6 ± 49.2
Cog. Independence: Difference—19.3 ± 38.2-11.7 ± 18.3
Mobility: Difference—0 ± 22.50.5 ± 17.2
Statistical analysis
  • Arm 2: Instruction Group vs Arm 3: Instruction + VSC Group · Wilcoxon (Mann-Whitney) · p = >0.05
PrimaryFrequency of Power Seat Function Usage

Frequency of power seat function usage was measured by the number of times of changing tilt and recline angles averaged by the duration that the participant occupied the wheelchair per day. The results of the difference between the baseline and week 7-8 (last 2 weeks) were shown here.

Time frame:
Every 2 weeks for 8 weeks following acquisition of wheelchair
Reported as:
Mean · times/hour
Frequency of Power Seat Function Usage
times/hourArm 1: Control GroupArm 2: Instruction GroupArm 3: Instruction + VSC Group
Freq of mod & max tilt (times/hr): Difference—.51 ± 2.520.03 ± 2.51
Freq of mod & max recline (times/hr): Difference—-0.43 ± 1.360.09 ± 0.15
Statistical analysis
  • Arm 2: Instruction Group vs Arm 3: Instruction + VSC Group · Wilcoxon (Mann-Whitney) · p = >0.05
PrimaryPower Wheelchair Usage

Power wheelchair usage was measured by the sum of distances that the power wheelchair traveled (km) divided by the duration of the wheelchair being occupied a day (hr). The result of the difference between the baseline and week 7-8 (last 2 weeks) was shown here.

Time frame:
Every 2 weeks for 8 weeks following acquisition of wheelchair
Reported as:
Mean · km/hour
Power Wheelchair Usage
km/hourArm 1: Control GroupArm 2: Instruction GroupArm 3: Instruction + VSC Group
Power Wheelchair Usage—0.17 ± 0.45-0.04 ± 0.08
Statistical analysis
  • Arm 2: Instruction Group vs Arm 3: Instruction + VSC Group · Wilcoxon (Mann-Whitney) · p = >0.05 (P values below 0.05 were considered statistically significant in this study.)
PrimaryWheelchair Occupancy

Wheelchair occupancy was measured by the sum of duration that the seat of the wheelchair was occupied. The results of the difference between the baseline and week 7-8 (last 2 weeks) were shown here.

Time frame:
Every 2 weeks for 8 weeks following acquisition of wheelchair
Reported as:
Mean · hours
Wheelchair Occupancy
hoursArm 1: Control GroupArm 2: Instruction GroupArm 3: Instruction + VSC Group
Wheelchair Occupancy—-.07 ± 1.9-0.4 ± 1.8
Statistical analysis
  • Arm 2: Instruction Group vs Arm 3: Instruction + VSC Group · Wilcoxon (Mann-Whitney) · p = >0.05

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Control Group—0/3 (0%)0/3 (0%)
Instruction Group—0/12 (0%)0/12 (0%)
Instruction and Virtual Coach Group—0/13 (0%)0/13 (0%)

Baseline characteristics

The average age of the participants was 53.2 years old (+/- 14.0 years old). Twelve out of 28 were female (42.9%). Two of the participants were veterans, and one of them was recruited from VA Wheelchair Seating clinic. Arm 1 (control group) was removed from the study through IRB modification because of difficulties in recruiting participants.

Age, Categorical
Age, Categorical(Participants)Control GroupInstruction GroupInstruction and Virtual Coach GroupTotal
<=18 years0000
Between 18 and 65 years311923
>=65 years0145
Age, Continuous
Age, Continuous(Years of age)Control GroupInstruction GroupInstruction and Virtual Coach GroupTotal
Mean47.0 ± 19.953.4 ± 9.154.5 ± 17.053.2 ± 14.0
Sex: Female, Male
Sex: Female, Male(Participants)Control GroupInstruction GroupInstruction and Virtual Coach GroupTotal
Female25512
Male17816
Region of Enrollment
Region of Enrollment(participants)Control GroupInstruction GroupInstruction and Virtual Coach GroupTotal
United States3121328
08

Study locations

1 site
  • VA Pittsburgh Health Care System
    Pittsburgh, Pennsylvania 15240, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 4, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00839098
Lead sponsor
VA Office of Research and Development
Responsible party
Sponsor
First posted
Feb 9, 2009
Start date
Nov 2011
Primary completion
Dec 2013
Completion
Nov 2014
Results posted
Feb 4, 2016
Last update
Feb 4, 2016

Study contacts

Rory A. Cooper, PhD
principal investigator · Director, Center of Excellence for Wheelchairs and Related Technology

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion